
© 2025 ARIVA.de
Realtime | Geld | Brief | Zeit |
---|---|---|---|
133,70 | 134,88 | 22:43 | |
134,40 | 134,82 | 22:00 |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
11:54 | Warner Music, Johnson & Johnson und mehr Dividenden im global market - Ex-Tag 27.05.2025 | ||
Do | DelveInsight Business Research, LLP: Johnson & Johnson's IMAAVY Gets FDA Approval, Taking on Top Players in Myasthenia Gravis Market | DelveInsight | The FDA has approved Johnson & Johnson's anti-FcRn antibody, nipocalimab, for the treatment of generalized myasthenia gravis. The drug will be sold under the brand name IMAAVY. This approval... ► Artikel lesen | |
Do | JNJ Down 6% in 3 Months: How to Play the Stock Amid Various Challenges | ||
Mi | Johnson & Johnson MedTech launches ultrasound catheter for imaging in cardiac ablation procedures | ||
Mi | J&J's Darzalex wins FDA advisers' backing as potential first treatment for smoldering myeloma |